BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?

BeiGene, Ltd. (BGNE) shares soared 5.3% in the last trading session to close at $246.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 22% gain over the past four weeks.The sudden rise in the stock price can be attributed to the positive investor mindset regarding the performance of the company’s marketed portfolio of drugs. Beigene currently has three approved medicines – Brukinsa (various blood cancers), Tevimbra (various sol ...